IMD-002: A FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND CLINICAL OUTCOMES OF PATIENTS WITH NON-MALIGNANT DISEASES WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MGTA-456

Project: Research project

Project Details

Description

IMD-002: A FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND CLINICAL OUTCOMES OF PATIENTS WITH NON-MALIGNANT DISEASES WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MGTA-456
StatusActive
Effective start/end date7/1/196/30/24

Funding

  • MAGENTA THERAPEUTICS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.